BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 14756000)

  • 1. [Visible spectrophotometric assay of ranitidine].
    Apostu M; Dorneanu V; Bibire N
    Rev Med Chir Soc Med Nat Iasi; 2003; 107(1):214-7. PubMed ID: 14756000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [UV spectrophotometric assay of famotidine in combination with picrolonic acid, picrolinate].
    Apostu M; Bibire N; Dorneanu V
    Rev Med Chir Soc Med Nat Iasi; 2005; 109(2):422-5. PubMed ID: 16607813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantification of ranitidine hydrochloride in the presence of its decomposition product by spectrophotometric methods. Application for kinetic study.
    Sokół A; Karpińska J; Talecka R; Starczewska B
    Acta Pol Pharm; 2011; 68(2):169-77. PubMed ID: 21485289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Ranitidine (Zantac). A new H2 receptor antagonist].
    Bendtsen F; Danø P
    Ugeskr Laeger; 1983 Nov; 145(47):3681-2. PubMed ID: 6140786
    [No Abstract]   [Full Text] [Related]  

  • 5. [Newly developed H2-receptor antagonists in the treatment of peptic ulcer disease].
    Simon B; Müller P; Dammann HG
    Wien Med Wochenschr; 1982 May; 132(10):223-8. PubMed ID: 6126962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Serum concentration of prolactin, gastrin and glycocholic acid in patient with peptic ulcer treated with ranitidine].
    Przybyłowski J; Kowalski D; Widłak H; Kowalska K; Maślany P
    Pol Tyg Lek; 1995; 50(1-35):794-6. PubMed ID: 11785198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Histamine H2 receptor blockaders: possibilities and prognosis in the use of stage III-IV preparations in the therapy of internal diseases].
    Miagkova LP; Grebenev AL; Kkhorshed AM
    Klin Med (Mosk); 1991 Mar; 69(3):27-34. PubMed ID: 1676773
    [No Abstract]   [Full Text] [Related]  

  • 8. Lansoprazole heals erosive reflux esophagitis resistant to histamine H2-receptor antagonist therapy.
    Sontag SJ; Kogut DG; Fleischmann R; Campbell DR; Richter J; Robinson M; McFarland M; Sabesin S; Lehman GA; Castell D
    Am J Gastroenterol; 1997 Mar; 92(3):429-37. PubMed ID: 9068463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nizatidine versus ranitidine in the treatment of peptic ulcer disease: report on the Dutch investigation as part of a European multicentre trial.
    Kuipers EJ; Hazenberg HJ; Quik RF; Hazenberg BP; de Zwart PA
    Neth J Med; 1990 Aug; 37(1-2):58-62. PubMed ID: 1977089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Therapy and prevention of duodenal and gastric ulcer with histamine-H2-receptor antagonists].
    Hentschel E
    Wien Med Wochenschr; 1983; 133(4-5):104-7. PubMed ID: 6134397
    [No Abstract]   [Full Text] [Related]  

  • 11. Ranitidine v. cimetidine in peptic ulcer.
    Drug Ther Bull; 1982 Jul; 20(15):57-9. PubMed ID: 6128213
    [No Abstract]   [Full Text] [Related]  

  • 12. [Is strong inhibition of gastric acid in the treatment of peptic ulcer sensible?].
    de Bruijne JW; Lamers CB
    Ned Tijdschr Geneeskd; 1989 Apr; 133(13):657-62. PubMed ID: 2566125
    [No Abstract]   [Full Text] [Related]  

  • 13. [A comparative evaluation of the efficacy of sucralfate and H2-histamine blockaders in treating peptic ulcer].
    Ivashkin VT; Tkachenko EI; Grinevich VB; Sultanov VK; Inozemtsev SA
    Ter Arkh; 1989; 61(8):59-62. PubMed ID: 2573963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Drugs used in the therapy of peptic ulcer with special reference to H2 receptor blockaders].
    De Natale G; De Natale F; Marino A
    Clin Ter; 1989 Apr; 129(1):3-16. PubMed ID: 2567647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Addition of misoprostol to ranitidine in non-responders to H2-blockers and pirenzepine.
    Walker S; Sarem-Aslani A; Treiber G; Klotz U; Bode JC
    Neth J Med; 1991 Feb; 38(1-2):18-23. PubMed ID: 1674363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug therapy of peptic ulcer disease.
    Ching CK; Lam SK
    Br J Hosp Med; 1995 Jul 12-Aug 15; 54(2-3):101-6. PubMed ID: 7551483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spectrophotometric determination of H(2)-receptor antagonists via their oxidation with cerium(IV).
    Darwish IA; Hussein SA; Mahmoud AM; Hassan AI
    Spectrochim Acta A Mol Biomol Spectrosc; 2008 Jan; 69(1):33-40. PubMed ID: 17442613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Long-term treatment of peptic ulcer with histamine H2 receptor blockaders: results of their use and new problems].
    Grigor'ev PIa; Isakov VA
    Klin Med (Mosk); 1991 Oct; 69(10):93-7. PubMed ID: 1685004
    [No Abstract]   [Full Text] [Related]  

  • 19. [Ranitidine: a new histamine H2 receptor blockader].
    Duan ZB
    Zhonghua Nei Ke Za Zhi; 1986 May; 25(5):309-12. PubMed ID: 2874962
    [No Abstract]   [Full Text] [Related]  

  • 20. Hypersensitivity reaction to ranitidine: description of a case and review of the literature.
    Foti C; Cassano N; Panebianco R; Calogiuri GF; Vena GA
    Immunopharmacol Immunotoxicol; 2009; 31(3):414-6. PubMed ID: 19694603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.